XYL-18275-23673
3 vaccinations
0 coded responses
18 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 984 / WA
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-27
Registered in v-safe
-
2021-04-27
Dose 1 — Pfizer-BioNTech
- 2021-04-27
- 2021-04-28
-
2021-04-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-24
Dose 2 — Pfizer-BioNTech
- 2021-10-26
-
2021-12-29
Dose 3 — Pfizer-BioNTech
- 2021-12-29
-
2021-12-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-04
- 2022-01-07
- 2022-01-12
- 2022-01-26
- 2022-02-04
- 2022-02-09
- 2022-03-30
- 2022-06-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-27 | Pfizer-BioNTech | |
| 2 | 2021-05-24 | Pfizer-BioNTech | No |
| 3 | 2021-12-29 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
No MedDRA codes.